Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

Grand Pharmaceutical Group Dividende

Zukünftiges Wachstum Kriterienprüfungen 3/6

Grand Pharmaceutical Group ist ein dividendenzahlendes Unternehmen mit einer aktuellen Rendite von 5.34%, die durch die Erträge gut gedeckt ist.

Wichtige Informationen

5.3%

Dividendenausschüttung

49%

Ausschüttungsquote

Durchschnittlicher Branchenertrag3.3%
Nächster Dividendenzahlungsterminn/a
Ex-Dividendendatumn/a
Dividende pro Aktien/a
Gewinn pro AktieHK$0.54
Erwartete Dividendenrendite in 3 Jahren6.8%

Aktuelle Dividendenentwicklung

Grand Pharmaceutical Group (HKG:512) Is Paying Out A Larger Dividend Than Last Year

Jun 05
Grand Pharmaceutical Group (HKG:512) Is Paying Out A Larger Dividend Than Last Year

Grand Pharmaceutical Group (HKG:512) Will Pay A Larger Dividend Than Last Year At HK$0.26

Apr 25
Grand Pharmaceutical Group (HKG:512) Will Pay A Larger Dividend Than Last Year At HK$0.26

Grand Pharmaceutical Group (HKG:512) Will Pay A Larger Dividend Than Last Year At HK$0.26

Mar 25
Grand Pharmaceutical Group (HKG:512) Will Pay A Larger Dividend Than Last Year At HK$0.26

Recent updates

Grand Pharmaceutical Group (HKG:512) Is Paying Out A Larger Dividend Than Last Year

Jun 05
Grand Pharmaceutical Group (HKG:512) Is Paying Out A Larger Dividend Than Last Year

Market Participants Recognise Grand Pharmaceutical Group Limited's (HKG:512) Earnings

May 22
Market Participants Recognise Grand Pharmaceutical Group Limited's (HKG:512) Earnings

Grand Pharmaceutical Group (HKG:512) Will Pay A Larger Dividend Than Last Year At HK$0.26

Apr 25
Grand Pharmaceutical Group (HKG:512) Will Pay A Larger Dividend Than Last Year At HK$0.26

Grand Pharmaceutical Group (HKG:512) Will Pay A Larger Dividend Than Last Year At HK$0.26

Mar 25
Grand Pharmaceutical Group (HKG:512) Will Pay A Larger Dividend Than Last Year At HK$0.26

We Think Grand Pharmaceutical Group (HKG:512) Can Stay On Top Of Its Debt

Oct 20
We Think Grand Pharmaceutical Group (HKG:512) Can Stay On Top Of Its Debt

Here's Why We Think Grand Pharmaceutical Group (HKG:512) Is Well Worth Watching

Sep 26
Here's Why We Think Grand Pharmaceutical Group (HKG:512) Is Well Worth Watching

Grand Pharmaceutical Group's (HKG:512) Dividend Will Be Increased To HK$0.14

Jun 04
Grand Pharmaceutical Group's (HKG:512) Dividend Will Be Increased To HK$0.14

Is Grand Pharmaceutical Group (HKG:512) A Risky Investment?

May 05
Is Grand Pharmaceutical Group (HKG:512) A Risky Investment?

Grand Pharmaceutical Group (HKG:512) Seems To Use Debt Quite Sensibly

Nov 21
Grand Pharmaceutical Group (HKG:512) Seems To Use Debt Quite Sensibly

Is Grand Pharmaceutical Group Limited (HKG:512) Trading At A 43% Discount?

Sep 05
Is Grand Pharmaceutical Group Limited (HKG:512) Trading At A 43% Discount?

Grand Pharmaceutical Group (HKG:512) Seems To Use Debt Quite Sensibly

Aug 16
Grand Pharmaceutical Group (HKG:512) Seems To Use Debt Quite Sensibly

Here's Why We Think Grand Pharmaceutical Group (HKG:512) Is Well Worth Watching

Jul 28
Here's Why We Think Grand Pharmaceutical Group (HKG:512) Is Well Worth Watching

Grand Pharmaceutical Group's (HKG:512) Dividend Will Be HK$0.11

May 29
Grand Pharmaceutical Group's (HKG:512) Dividend Will Be HK$0.11

Is Grand Pharmaceutical Group Limited (HKG:512) Trading At A 45% Discount?

Apr 08
Is Grand Pharmaceutical Group Limited (HKG:512) Trading At A 45% Discount?

Grand Pharmaceutical Group (HKG:512) Has A Rock Solid Balance Sheet

Mar 22
Grand Pharmaceutical Group (HKG:512) Has A Rock Solid Balance Sheet

If You Like EPS Growth Then Check Out Grand Pharmaceutical Group (HKG:512) Before It's Too Late

Jan 24
If You Like EPS Growth Then Check Out Grand Pharmaceutical Group (HKG:512) Before It's Too Late

These 4 Measures Indicate That Grand Pharmaceutical Group (HKG:512) Is Using Debt Safely

Dec 13
These 4 Measures Indicate That Grand Pharmaceutical Group (HKG:512) Is Using Debt Safely

Grand Pharmaceutical Group Limited's (HKG:512) Intrinsic Value Is Potentially 45% Above Its Share Price

Nov 27
Grand Pharmaceutical Group Limited's (HKG:512) Intrinsic Value Is Potentially 45% Above Its Share Price

With EPS Growth And More, China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Is Interesting

Oct 25
With EPS Growth And More, China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Is Interesting

China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Seems To Use Debt Rather Sparingly

Sep 01
China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Seems To Use Debt Rather Sparingly

Do China Grand Pharmaceutical and Healthcare Holdings's (HKG:512) Earnings Warrant Your Attention?

Jul 12
Do China Grand Pharmaceutical and Healthcare Holdings's (HKG:512) Earnings Warrant Your Attention?

We Think China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Can Stay On Top Of Its Debt

Apr 26
We Think China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Can Stay On Top Of Its Debt

Calculating The Fair Value Of China Grand Pharmaceutical and Healthcare Holdings Limited (HKG:512)

Apr 08
Calculating The Fair Value Of China Grand Pharmaceutical and Healthcare Holdings Limited (HKG:512)

Here's Why We Think China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Is Well Worth Watching

Mar 24
Here's Why We Think China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Is Well Worth Watching

If You Had Bought China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Shares Five Years Ago You'd Have Earned 332% Returns

Mar 11
If You Had Bought China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Shares Five Years Ago You'd Have Earned 332% Returns

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab

Stabile Dividende: Während die Dividendenzahlungen stabil waren, zahlt 512 seit weniger als 10 Jahren eine Dividende.

Wachsende Dividende: 512Die Dividendenzahlungen des Unternehmens sind gestiegen, aber das Unternehmen zahlt erst seit 5 Jahren eine Dividende.


Dividendenrendite im Vergleich zum Markt

Grand Pharmaceutical Group Dividendenrendite im Vergleich zum Markt
Wie sieht die Dividendenrendite von 512 im Vergleich zum Markt aus?
SegmentDividendenrendite
Unternehmen (512)5.3%
Untere 25 % des Marktes (HK)3.2%
Markt Top 25 % (HK)7.6%
Branchendurchschnitt (Pharmaceuticals)3.3%
Analystenprognose in 3 Jahren (512)6.8%

Bemerkenswerte Dividende: 512Die Dividende des Unternehmens (5.39%) ist höher als die der untersten 25 % der Dividendenzahler auf dem Markt Hong Kong (3.12%).

Hohe Dividende: 512Die Dividende des Unternehmens (5.39%) ist im Vergleich zu den besten 25 % der Dividendenzahler auf dem Markt Hong Kong (7.56%) niedrig.


Gewinnausschüttung an die Aktionäre

Abdeckung der Erträge: Mit einer relativ niedrigen Ausschüttungsquote (48.5%) sind die Dividendenzahlungen von 512 gut durch die Erträge gedeckt.


Barausschüttung an die Aktionäre

Cashflow-Deckung: Mit einer relativ niedrigen Ausschüttungsquote (47%) sind die Dividendenzahlungen von 512 durch den Cashflow gut gedeckt.


Discover strong dividend paying companies